EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death

Lisa Wahlgren, Anna-Karin Kroksmark, Anders Lindblad, Mar Tulinius, Kalliopi Sofou

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12372-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2024. Verfasst von Lisa Wahlgren und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden. lisa.wahlgren@vgregion.se. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Life Expectancy, Comorbidity, Cause of Death. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: grants from the Swedish state under the agreement between the Swedish government and the country councils, ALF-agreement, The foundation for Bo-Göran Bremert´s memory, The foundation of Linnéa and Joseph Carlsson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder with progressive decline of pulmonary function increasing the risk of early mortality. The aim of this study was to explore the respiratory-related comorbidities, and the effect of these comorbidities and treatments on life expectancy and causes of death.

Methods

All male patients living in Sweden with DMD, born and deceased 1970–2019, were included. Data regarding causes of death were collected from the Cause of Death Registry and cross-checked with the medical records along with diagnostics and relevant clinical features.

Results

Hundred and twenty nine patients were included with a median lifespan of 24.3 years. Acute respiratory failure accounted for 63.3% of respiratory-related causes of death. 70.1% suffered at least one pneumonia, with first episode at a median age of 17.8 years. Hypoventilation was found in 73.0% with onset at 18.1 years. 60.5% had their first pneumonia before established hypoventilation. Age at onset of hypoventilation showed a strong correlation with age at first pneumonia. First pneumonia and scoliosis non-treated with scoliosis surgery increased the risk of dying of respiratory-related causes. In 10% of the patients, first pneumonia resulted in acute tracheostomy or early death. Patients treated with assisted ventilation had higher life expectancy compared to untreated patients.

Conclusions

Our results highlight the importance of identifying subclinical hypoventilation in a timely manner and the importance of an active treatment regime upon clinical signs of pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneLife ExpectancyComorbidityCause of DeathRespiratory InsufficiencyHumansMaleAdolescentAdultYoung AdultSwedenChildPneumoniaRegistriesHypoventilationChild, Preschool

Stichwörter der Autor:innen

Cause of deathDuchenne muscular dystrophyPulmonaryRisk factorsSurvival

Autor:innen und Institutionen

  • The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden. lisa.wahlgren@vgregion.se.
  • Department of Pediatrics, Lnstitute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. lisa.wahlgren@vgregion.se.
  • Department for Health and Rehabilitation/Physiotherapy, University of Gothenburg, Gothenburg, Sweden.
  • The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Pediatrics, Lnstitute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Förderung

  • grants from the Swedish state under the agreement between the Swedish government and the country councils, ALF-agreement
  • The foundation for Bo-Göran Bremert´s memory
  • The foundation of Linnéa and Joseph Carlsson
  • the Swedish fundraising foundation for Muscular Dystrophy Research;
  • University of Gothenburg

Zitieren

APA

Wahlgren, L., Kroksmark, A. K., Lindblad, A., Tulinius, M., & Sofou, K. (2024). Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death. Journal of Neurology. https://doi.org/10.1007/s00415-024-12372-7

Vancouver

Wahlgren L, Kroksmark AK, Lindblad A, Tulinius M, Sofou K. Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death. Journal of Neurology. 2024. doi:10.1007/s00415-024-12372-7

BibTeX
@article{Wahlgren2024,
  author = {Wahlgren, Lisa and Kroksmark, Anna-Karin and Lindblad, Anders and Tulinius, Mar and Sofou, Kalliopi},
  title = {Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12372-7}
}
Kostenlos starten →